Efficacy and safety of antibody-drug conjugate combination therapy in advanced urothelial carcinoma
{{output}}
Antibody-drug conjugates (ADCs) are revolutionizing the treatment landscape of advanced urothelial carcinoma (aUC). We systematically reviewed the PubMed and Embase databases for published clinical trials evaluating ADC-combination regimens in aUC. We extracte... ...
